BIIB091 - Moligand™, ≥98% , Inhibitor of BMX non-receptor tyrosine kinase;Inhibitor of Bruton tyrosine kinase;Inhibitor of tyrosine kinase with immunoglobulin like and EGF like domains 1, CAS No.2247614-80-6, Inhibitor of BMX non-receptor tyrosine kinase;Inhibitor of Bruton tyrosine kinase;Inhibitor of tyrosine kinase with immunoglobulin like and EGF like domains 1

CAS: 2247614-80-6 Cat. No.: B608067 Summenformel: C₂₈H₃₄N₁₀O₂ Molekulargewicht: 542.64

GRADE & PURITY Moligand™, ≥98%

Synonyms

BIIB-091;compound 51

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

Übersicht

BIIB091 is a potent, selective and reversible BTK inhibitor, with an IC50 of <0.5 nM. BIIB091 binds the BTK protein to sequester TYR-551 into an inactive conformation with excellent affinity. BIIB091 can be used for the research of multiple sclerosis

Specifications

Synonyme

BIIB-091;compound 51

Spezifikationen & Reinheit

Moligand™, ≥98%

Storage

Store at -20°C

Verschickt in

Ice chest + Ice pads

Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.

Note

Moligand™

Aktionsart

INHIBITOR

Mechanismus der Wirkung

Inhibitor of BMX non-receptor tyrosine kinase;Inhibitor of Bruton tyrosine kinase;Inhibitor of tyrosine kinase with immunoglobulin like and EGF like domains 1

Reinheit

≥98%

Namen und Kennungen

• Molekulargewicht: 542.64

Zugehörige Ziele (menschlich)

BTK Tclin Tyrosine-protein kinase BTK (0 Activities)

Discover Target: BTK

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

BMX Tchem Cytoplasmic tyrosine-protein kinase BMX (0 Activities)

Discover Target: BMX

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

TIE1 Tchem Tyrosine-protein kinase receptor Tie-1 (0 Activities)

Discover Target: TIE1

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)